Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad
Authors
Keywords
Biologic drugs, TNF inhibitors, Rituximab, Arrhythmic risk, Sudden cardiac death, Atrial fibrillation, Systemic inflammation
Journal
IMMUNOLOGIC RESEARCH
Volume 65, Issue 1, Pages 262-275
Publisher
Springer Nature
Online
2016-07-16
DOI
10.1007/s12026-016-8833-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis
- (2016) Pietro Enea Lazzerini et al. EUROPEAN HEART JOURNAL
- Effect of Infliximab Treatment on QT Intervals in Patients With Ankylosing Spondylitis: TABLE 1.
- (2016) Soner Senel et al. JOURNAL OF INVESTIGATIVE MEDICINE
- The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
- (2015) Camille Roubille et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome
- (2015) Ängla Mantel et al. EUROPEAN HEART JOURNAL
- Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Patompong Ungprasert et al. International Journal of Rheumatic Diseases
- Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study
- (2015) Hsien-Yi Chiu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation
- (2015) Pietro Enea Lazzerini et al. ARTHRITIS CARE & RESEARCH
- An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
- (2015) Vijay U. Rao et al. Arthritis & Rheumatology
- The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
- (2015) Sella Aarrestad Provan et al. PLoS One
- Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation
- (2014) Pietro Enea Lazzerini et al. AUTOIMMUNITY REVIEWS
- Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature
- (2014) Inger L Meek et al. BMC MUSCULOSKELETAL DISORDERS
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
- (2014) Ignatios Ikonomidis et al. Circulation-Cardiovascular Imaging
- Managing risks of TNF inhibitors: An update for the internist
- (2014) J. HADAM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study
- (2014) Ashit Syngle et al. CLINICAL RHEUMATOLOGY
- Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
- (2014) Alper Sijl et al. CURRENT PHARMACEUTICAL DESIGN
- Reflex control of inflammation by sympathetic nerves, not the vagus
- (2014) D. Martelli et al. JOURNAL OF PHYSIOLOGY-LONDON
- Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis
- (2014) Gurkan Acar et al. Modern Rheumatology
- Rituximab-Vincristine Chemotherapy-Induced Acute Anterior Wall Myocardial Infarction with Cardiogenic Shock
- (2014) Ambuj Roy et al. TEXAS HEART INSTITUTE JOURNAL
- Acute Myocardial Infarction after First Dose of Rituximab Infusion
- (2014) Ajay Gogia et al. Turkish Journal of Hematology
- Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis
- (2013) Pietro Enea Lazzerini et al. European Journal of Internal Medicine
- Acute coronary syndrome caused by infliximab in a patient with ankylosing spondylitis
- (2013) Ashok Kumar et al. International Journal of Rheumatic Diseases
- Myocardial infarction after rituximab infusion
- (2013) Dimitri Renard et al. NEUROMUSCULAR DISORDERS
- Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden
- (2013) V. F. Panoulas et al. RHEUMATOLOGY
- Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study
- (2013) Joseph J. Keller et al. RHEUMATOLOGY INTERNATIONAL
- Increased Risk of Atrial and Ventricular Arrhythmia in Long-Lasting Psoriasis Patients
- (2013) Hakki Simsek et al. TheScientificWorldJOURNAL
- Expression change of TNF–α in myocardium and hepatic tissue of rats with compound stress of hyperthermia and lipopolysaccharide
- (2013) Xiao-Jun Zhang et al. Asian Pacific Journal of Tropical Medicine
- Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
- (2012) Anna Jamnitski et al. ANNALS OF THE RHEUMATIC DISEASES
- Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
- (2012) Armen Yuri Gasparyan et al. CURRENT PHARMACEUTICAL DESIGN
- Inflammatory arthritis as a novel risk factor for cardiovascular disease
- (2012) Holly John et al. European Journal of Internal Medicine
- Triggering of cardiac arrhythmic events in long QT syndrome: lessons from funny bunnies
- (2012) Chia Tung Wu et al. JOURNAL OF PHYSIOLOGY-LONDON
- Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris
- (2012) Ahmet Bacaksiz et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population-based study
- (2011) Shelagh M. Szabo et al. ARTHRITIS AND RHEUMATISM
- Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
- (2011) Ole Ahlehoff et al. EUROPEAN HEART JOURNAL
- Ischemic ventricular arrhythmias: Experimental models and their clinical relevance
- (2011) José M. Di Diego et al. HEART RHYTHM
- Rituximab induced myocardial infarction: A fatal drug reaction
- (2011) Palamalai Arunprasath et al. Journal of Cancer Research and Therapeutics
- Biological Drug Treatment of Rheumatoid Arthritis and Spondyloarthritis: Effects on QT Interval and QT Dispersion
- (2011) M. DI FRANCO et al. JOURNAL OF RHEUMATOLOGY
- Safety of biologic therapy in rheumatoid arthritis
- (2011) Robert S. Woodrick et al. Nature Reviews Rheumatology
- Tumor necrosis factor superfamily molecules in acute coronary syndromes
- (2010) Pål Aukrust et al. ANNALS OF MEDICINE
- Increased prevalence of diastolic dysfunction in rheumatoid arthritis
- (2010) K. P. Liang et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis
- (2010) Sylvain Mathieu et al. ARTHRITIS CARE & RESEARCH
- Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study
- (2010) Yasuyuki Kobayashi et al. ARTHRITIS RESEARCH & THERAPY
- Atrial Fibrillation in Congestive Heart Failure
- (2010) Steven A. Lubitz et al. Heart Failure Clinics
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction
- (2009) Rebecca L. Rudominer et al. ARTHRITIS AND RHEUMATISM
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Doxorrubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes
- (2009) Miriam Moreno et al. MEDICINA CLINICA
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
- (2008) Sherine E. Gabriel AMERICAN JOURNAL OF MEDICINE
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- Atrial Remodeling and Atrial Fibrillation
- (2008) Stanley Nattel et al. Circulation-Arrhythmia and Electrophysiology
- Complete atrioventricular block induced by rituximab in monotherapy in an aged patient with non-Hodgkin’s diffuse large B-cell lymphoma
- (2008) José Manuel Cervera Grau et al. Clinical & Translational Oncology
- The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study
- (2008) Pinar Borman et al. CLINICAL RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now